Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 5:02 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 26-Feb-24 | Sale (Planned) | 354 | $425.70 | $150,698.00 | (< 1%) 56.16K to 55.8K | |
| 27-Feb-24 5:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 3,309 | $431.79 | $1,428,790.00 | (6%) 59.47K to 56.16K | |
| 23-Feb-24 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-24 | Private Sale (Planned) | 360 | $421.77 | $151,837.00 | (< 1%) 59.83K to 59.47K | |
| 21-Feb-24 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 3,373 | $420.58 | $1,418,620.00 | (5%) 63.68K to 60.31K | |
| 21-Feb-24 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Sale (Planned) | 480 | $420.79 | $201,979.00 | (< 1%) 60.31K to 59.83K | |
| 21-Feb-24 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 4,499 | $424.01 | $1,907,620.00 | (7%) 68.18K to 63.68K | |
| 13-Feb-24 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 314 | $420.24 | $131,955.00 | (< 1%) 68.49K to 68.18K | |
| 13-Feb-24 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 2,100 | $422.74 | $887,754.00 | (3%) 70.59K to 68.49K | |
| 08-Feb-24 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 7,114 | -- | -- | 11% 63.48K to 70.59K | |
| 08-Feb-24 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 14,842 | -- | -- | 31% 48.64K to 63.48K | |
| 25-Aug-23 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Aug-23 | Private Sale (Planned) | 2,500 | $355.00 | $887,500.00 | (5%) 51.14K to 48.64K | |
| 14-Aug-23 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-23 | Private Sale (Planned) | 5,750 | $345.79 | $1,988,290.00 | (10%) 56.89K to 51.14K | |
| 28-Feb-23 5:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Feb-23 | Sale (Planned) | 354 | $287.48 | $101,768.00 | (< 1%) 57.16K to 56.8K | |
| 28-Feb-23 5:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 3,308 | $289.12 | $956,409.00 | (5%) 60.47K to 57.16K | |
| 22-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-23 | Sale (Planned) | 480 | $293.75 | $141,002.00 | (< 1%) 60.95K to 60.47K | |
| 22-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 4,498 | $292.85 | $1,317,240.00 | (7%) 65.44K to 60.95K | |
| 16-Feb-23 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Feb-23 | Private Sale (Planned) | 320 | $298.52 | $95,526.50 | (< 1%) 65.77K to 65.44K | |
| 14-Feb-23 5:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 2,995 | $298.26 | $893,289.00 | (4%) 69.03K to 66.04K | |
| 14-Feb-23 5:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Sale (Planned) | 275 | $298.99 | $82,222.90 | (< 1%) 66.04K to 65.77K | |
| 14-Feb-23 5:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 1,377 | $294.33 | $405,292.00 | (2%) 70.41K to 69.03K | |
| 03-Feb-23 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 24,322 | -- | -- | 53% 46.09K to 70.41K | |
| 10-Aug-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Aug-22 | Private Sale (Planned) | 1,400 | $298.97 | $418,557.00 | (3%) 47.49K to 46.09K | |
| 21-Mar-22 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Mar-22 | Private Sale (Planned) | 2,833 | $250.11 | $708,572.00 | (6%) 50.19K to 47.36K | |
| 28-Feb-22 5:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-22 | Sale (Planned) | 325 | $230.95 | $75,058.10 | (< 1%) 50.51K to 50.19K | |
| 28-Feb-22 5:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 2,590 | $227.86 | $590,157.00 | (5%) 53.1K to 50.51K | |
| 22-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-22 | Sale (Planned) | 519 | $231.00 | $119,889.00 | (< 1%) 53.62K to 53.1K | |
| 22-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 4,114 | $232.51 | $956,546.00 | (7%) 57.74K to 53.62K | |
| 14-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-22 | Sale (Planned) | 290 | $235.09 | $68,175.10 | (< 1%) 58.03K to 57.74K | |
| 14-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 1,230 | $237.74 | $292,420.00 | (2%) 59.26K to 58.03K | |
| 03-Feb-22 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 27,714 | -- | -- | 88% 31.54K to 59.26K | |
| 26-Feb-21 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 1,036 | $217.57 | $225,403.00 | (3%) 32.47K to 31.43K | |
| 19-Feb-21 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-21 | Payment of Exercise | 2,000 | $211.75 | $423,500.00 | (6%) 34.47K to 32.47K | |
| 12-Feb-21 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 1,230 | $214.16 | $263,417.00 | (3%) 35.7K to 34.47K | |
| 05-Feb-21 4:59 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 22,960 | -- | -- | 180% 12.74K to 35.7K | |
| 19-May-20 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-May-20 | Private Sale (Planned) | 120 | $284.00 | $34,080.10 | (< 1%) 12.86K to 12.74K | |
| 08-May-20 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Option Exercise | 966 | $174.06 | $168,146.00 | 8% 12.74K to 13.7K | (3%) |
| 08-May-20 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Planned Private Option Sale | 966 | $272.70 | $263,431.00 | (7%) 13.7K to 12.74K | |
| 26-Feb-20 4:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-20 | Sale (Planned) | 1,296 | $233.17 | $302,187.00 | (9%) 14.03K to 12.74K | |
| 26-Feb-20 4:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-20 | Payment of Exercise | 1,036 | $239.23 | $247,842.00 | (7%) 15.07K to 14.03K | |
| 19-Feb-20 4:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-20 | Sale (Planned) | 1,279 | $243.62 | $311,585.00 | (8%) 16.35K to 15.07K | |
| 19-Feb-20 4:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-20 | Payment of Exercise | 597 | $241.50 | $144,176.00 | (4%) 16.95K to 16.35K | |
| 07-Feb-20 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-20 | Option Exercise | 967 | $174.04 | $168,302.00 | 6% 16.95K to 17.91K | |
| 07-Feb-20 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-20 | Planned Option Sale | 967 | $239.43 | $231,527.00 | (5%) 17.91K to 16.95K | |
| 07-Feb-20 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-20 | Grant | 9,694 | -- | -- | 134% 7.25K to 16.95K | |
| 10-Jan-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Jan-20 | Option Exercise | 1,675 | $187.53 | $314,113.00 | 23% 7.25K to 8.93K | (10%) |
| 10-Jan-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Jan-20 | Planned Private Option Sale | 1,675 | $227.53 | $381,113.00 | (19%) 8.93K to 7.25K | |
| 19-Nov-19 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-19 | Private Sale (Planned) | 5 | $205.95 | $1,029.75 | (< 1%) 7.26K to 7.25K | |
| 15-Nov-19 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Nov-19 | Option Exercise | 2,853 | $155.57 | $443,841.00 | 39% 7.25K to 10.11K | |
| 15-Nov-19 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Nov-19 | Planned Option Sale | 2,853 | $205.59 | $586,548.00 | (28%) 10.11K to 7.25K | |
| 03-Oct-19 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Oct-19 | Market Sale (Planned) | 444 | $167.69 | $74,454.40 | (6%) 7.7K to 7.25K | (< 1%) |